期刊文献+

甲状腺素对阿尔茨海默病患者淋巴细胞糖原合酶激酶-3的影响

The Effects of Thyroid on Glycogen Synthase Kinase-3 Activity in Lymphocytes in Alzheimer Disease
下载PDF
导出
摘要 目的:探讨甲状腺素对阿尔茨海默病患者淋巴细胞糖原合酶激酶-3(glycogen synthase kinase-3,GSK-3)的影响。方法:用^(32)P标记法检测正常老年人组,阿尔茨海默病(Alzheimer's disease,AD)组,甲状腺素治疗组淋巴细胞糖原合酶激酶-3的变化,并用放射免疫法检测这些组血清三碘甲状腺原氨酸(triiodothyronine,T_3)、T_4甲状腺素(tetraiodothyronine,T_4)、游离三碘甲状腺原氨酸(freetriiodothyronine,FT_3)、T_4游离甲状腺素(free thyroxine,FT_4)、促甲状腺激素(thyrotropin,TSH)的变化。结果:与对照组比较,AD组及甲状腺素组治疗前T_3及FT_3的含量存在明显降低(P<0.01,P<0.01)。TSH水平也明显降低(P<0.01,P<0.01),且伴有淋巴细胞GSK-3活性的明显降低(P<0.01,P<0.01)。甲状腺素治疗后,T_3、FT_3、TSH水平明显恢复(P<0.01),淋巴细胞GSK-3的活性明显降低(P<0.01),与对照组无明显差别(P>0.05)。结论:AD患者甲状腺功能降低,且伴有GSK-3活性升高,甲状腺素治疗后甲状腺功能恢复,且GSK-3活性降低,提示甲状腺素对AD治疗可能有价值。 Objective:our pruepose was to explore the effects of thyroid on glycogen synthase kinase-3activity in lymphocytes in alzheimer disease.methods:the activity of GSK-3 was measured ty 32^p liquild scintillography for incorporated radioactivity,and the levels of serum triiodothy romine(T3) ,teraiodothyronine(T4),free triiodotyronine(FT1),free thyroxine(FT4),and thyrotropin(TSH)were measured by radioimmunoassay in control group.Alzheimer disease group and thyroid treament group.Results:Compared with control group,the levels of T3、FT3and TSH were lower in AD group and in thyroid group unpretreatment(P〈0.01,P〈0.01),moreover,GSK-3 activity was also increased in these two groups(P〈0.01,P〈0.01),The higher levels of T3,FT3 and TSH were induced in thyroid treatment grop(P〈0.01),and the activity of GSK-3 activity in AD group,thyroid function was recoveried and low level of GSK-3 activity was reversed after thyroid treatment. Out results suggust that thyroid be valuble for AD treatment.
出处 《中国医药导刊》 2011年第7期1222-1224,共3页 Chinese Journal of Medicinal Guide
基金 中国博士后科学基金资助项目(20060390635) 上海市浦东新区社发局基金资助项目(PW2008A-8)
关键词 阿尔茨海默病 糖原合酶激酶-3 甲状腺素 Alzheiner disease Glycogensynthase kinase-3 Thyroid
  • 相关文献

参考文献7

  • 1Luo L,Stopa EG.Thyrotropin releasing hormone inhibits tau phosphorylation by dual signaling pathways in hippocampal neurons[J].J Alzheimers Dis,2004;6(5):527-536.
  • 2Wang JZ,Grundke-Iqbal I,Iqbal K.Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration[J].Eur J Neurosci,2007;25(1):59-68.
  • 3Phiel CJ,Wilson CA,Lee VM,et al.Gsk-3α regulates production of Alzheimer's disease amyloid-βpeptides[J].Nature,2003;423(6938):435-438.
  • 4Wang Y,Zhang JX,Du XX,et al.Temporal correlation of the memory deficit with Alzheimer-like lesions induced by activation of glycogen synthase kinase-3[J].J Neurochem,2008;106(6):2364-2374.
  • 5Hye A,Kerr F,Archer N,et al.Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's diseas[J].Neurosci Lett,2005;373(1):1-4.
  • 6Kapaki E,Ilias I,Paraskevas GP,et al.Thyroid function in patients with Alzheimer's disease treated with cholinesterase inhibitors,2003;63(4):389-392.
  • 7Prinz PN,Scanlan JM,Vitaliano PP,et al.Thyroid hormones:positive relationships with cognition in healthy,euthyroid older men.J Gerontol A Biol Sci Med Sci,1999;54(3):111-116.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部